Trials / Withdrawn
WithdrawnNCT04215549
The Cost of Obsessive-compulsive Disorder (OCD) in China
The Cost of Obsessive-compulsive Disorder (OCD) in China: Multi-center Cross-sectional Survey Based on Hospital
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.
Detailed description
Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | cross sectional study,no intervention |
Timeline
- Start date
- 2020-01-02
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-01-02
- Last updated
- 2020-11-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04215549. Inclusion in this directory is not an endorsement.